1722MO Updated efficacy results of olverembatinib (HQP1351) in patients with succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and potential mechanisms of action (MOA)
2024 · Annals of Oncology · 3 citations
https://doi.org/10.1016/j.annonc.2024.08.1814